The Impact of Comorbid Chronic Pain on Older Adults With Depression in Behavioral Activation

Launched by TEESSIDE UNIVERSITY · Dec 7, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how chronic pain affects older adults who are also experiencing depression, specifically during a type of therapy called behavioral activation (BA). Behavioral activation is a brief psychological treatment that helps people engage in activities they enjoy and that can improve their mood. Researchers want to understand how living with chronic pain, which is pain lasting more than three months, influences the way older adults respond to this treatment.

To participate in the study, individuals must be older adults who have previously agreed to take part in a related study and are currently experiencing chronic pain. They should have had either a positive or negative response to treatment, which will be measured using a specific questionnaire about their mood. Participants can expect to share their experiences with pain and depression through interviews, helping researchers gain insights into the challenges faced by older adults in managing both conditions. This study is currently recruiting participants of all genders, and their feedback will be valuable in shaping better treatment approaches for those dealing with chronic pain and depression.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Previously provided optional consent to participate in a qualitative study as part of the BASIL+ trial
• • 2. Not enrolled or offered to take part in any other qualitative study linked with the BASIL+ trial (i.e, the nested BASIL+ qualitative study or the therapeutic alliance sub-study)
• • 3. Suffering chronic pain. This will be assumed by individual scores on the (short-from 12) SF-12 and EuroQoal 5th Edition (EQ-5D) at baseline in the BASIL + trial. Patients who have responded as "moderate, quite a bit or extremely" on question 8 of the SF-12 at baseline and/or responded as having "moderate or extreme pain or discomfort" on the EQ-5D question 4 at baseline will be "assumed" to experiencing some level of pain. A further 2 telephone screening questions by the PI of this sub-study (Alexandra Carne) will assess how often patients have pain and how pain limits their life/work activities in the last 3 months. This will confirm the presence of chronic pain.
• • 4. Participants will have had either a 'favourable' or 'non' favourable' response to treatment. This is defined as having a change of 0.5 SD on the PHQ-9 from baseline to the primary outcome point at 3 months.
• Exclusion Criteria:
• • 1. Does not fulfill the inclusion criteria

Trial Officials